Table 2. Tumor necrosis factor-alpha and transforming growth factor beta 1 levels in bronchoalveolar lavage fluid.
| Control | Early bleomycin+saline |
Early bleomycin+montelukast | Late bleomycin+saline |
Late bleomycin+montelukast |
|
| Mean±SD | Mean±SD | Mean±SD | Mean±SD | Mean±SD | |
| TNF-a(pg/mL) | 4.0±1.4 | 44.1±14.5*† | 11.8±4.7§ | 30.3±5.7* | 14.3±4.1¶ |
| TGF-b1 (pg/mL) | 28.6±6.6 | 82.3±14.1*‡ | 32.0±5.8§ | 60.1±2.9* | 34.8±3.8§ |
| TNF-a: Tumor necrosis factor-alpha; TGF-b1: Transforming growth factor beta 1; * p<0.001 vs. control; ¶ p<0.01; § p<0.001 vs. B+saline groups in same term; † p<0.05 vs. late bleomycin + saline group; ‡ p<0.001 vs. late bleomycin + saline group. Data are means ± standard deviations from eight rats for each group. | |||||